These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9111302)

  • 1. Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1997 Apr; 40(8):1276-86. PubMed ID: 9111302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of formaldehyde and DNA-adriamycin or DNA-daunomycin adducts, initiated through redox chemistry of dithiothreitol/iron, xanthine oxidase/NADH/iron, or glutathione/iron.
    Taatjes DJ; Gaudiano G; Koch TH
    Chem Res Toxicol; 1997 Sep; 10(9):953-61. PubMed ID: 9305576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1996 Oct; 39(21):4135-8. PubMed ID: 8863788
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.
    Taatjes DJ; Fenick DJ; Koch TH
    J Med Chem; 1998 Apr; 41(8):1306-14. PubMed ID: 9548820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxoform and Daunoform: anthracycline-formaldehyde conjugates toxic to resistant tumor cells.
    Fenick DJ; Taatjes DJ; Koch TH
    J Med Chem; 1997 Aug; 40(16):2452-61. PubMed ID: 9258351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The power and potential of doxorubicin-DNA adducts.
    Cutts SM; Nudelman A; Rephaeli A; Phillips DR
    IUBMB Life; 2005 Feb; 57(2):73-81. PubMed ID: 16036566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depurinating acylfulvene-DNA adducts: characterizing cellular chemical reactions of a selective antitumor agent.
    Gong J; Vaidyanathan VG; Yu X; Kensler TW; Peterson LA; Sturla SJ
    J Am Chem Soc; 2007 Feb; 129(7):2101-11. PubMed ID: 17256933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiol-dependent DNA damage produced by anthracycline-iron complexes. The structure-activity relationships and molecular mechanisms.
    Muindi J; Sinha BK; Gianni L; Myers C
    Mol Pharmacol; 1985 Mar; 27(3):356-65. PubMed ID: 2983184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin.
    Frederick CA; Williams LD; Ughetto G; van der Marel GA; van Boom JH; Rich A; Wang AH
    Biochemistry; 1990 Mar; 29(10):2538-49. PubMed ID: 2334681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
    Taatjes DJ; Fenick DJ; Koch TH
    Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for the formation of anthracycline-DNA adducts.
    Cutts SM; Parker BS; Swift LP; Kimura KI; Phillips DR
    Anticancer Drug Des; 2000 Oct; 15(5):373-86. PubMed ID: 11354313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C.
    Suresh Kumar G; Lipman R; Cummings J; Tomasz M
    Biochemistry; 1997 Nov; 36(46):14128-36. PubMed ID: 9369485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of formaldehyde-mediated covalent adducts of adriamycin with DNA.
    Luce RA; Sigurdsson ST; Hopkins PB
    Biochemistry; 1999 Jul; 38(27):8682-90. PubMed ID: 10393543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formaldehyde-activated Pixantrone is a monofunctional DNA alkylator that binds selectively to CpG and CpA doublets.
    Evison BJ; Chiu F; Pezzoni G; Phillips DR; Cutts SM
    Mol Pharmacol; 2008 Jul; 74(1):184-94. PubMed ID: 18413664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative correlation of drug bioactivation and deoxyadenosine alkylation by acylfulvene.
    Neels JF; Gong J; Yu X; Sturla SJ
    Chem Res Toxicol; 2007 Oct; 20(10):1513-9. PubMed ID: 17900171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitosene-DNA adducts. Characterization of two major DNA monoadducts formed by 1,10-bis(acetoxy)-7-methoxymitosene upon reductive activation.
    Maliepaard M; de Mol NJ; Tomasz M; Gargiulo D; Janssen LH; van Duynhoven JP; van Velzen EJ; Verboom W; Reinhoudt DN
    Biochemistry; 1997 Jul; 36(30):9211-20. PubMed ID: 9230054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of adriamycin-DNA adducts by accelerator mass spectrometry.
    Coldwell K; Cutts SM; Ognibene TJ; Henderson PT; Phillips DR
    Methods Mol Biol; 2010; 613():103-18. PubMed ID: 19997880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of anthracyclines and synthetic hexanucleotides. Structural factors influencing sequence specificity.
    Rizzo V; Battistini C; Vigevani A; Sacchi N; Razzano G; Arcamone F; Garbesi A; Colonna FP; Capobianco M; Tondelli L
    J Mol Recognit; 1989 Nov; 2(3):132-41. PubMed ID: 2636902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barminomycin functions as a potent pre-activated analogue of Adriamycin.
    Moufarij MA; Cutts SM; Neumann GM; Kimura K; Phillips DR
    Chem Biol Interact; 2001 Nov; 138(2):137-53. PubMed ID: 11672697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between morpholinyl anthracyclines and DNA. The crystal structure of a morpholino doxorubicin bound to d(CGTACG).
    Cirilli M; Bachechi F; Ughetto G; Colonna FP; Capobianco ML
    J Mol Biol; 1993 Apr; 230(3):878-89. PubMed ID: 8478940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.